— Know what they know.
/
Not Investment Advice
Also trades as: 0A8E.L (LSE) · $vol 0M

XERS NASDAQ

Xeris Biopharma Holdings, Inc.
1W: -6.1% 1M: +6.3% 3M: +24.7% YTD: +42.2% 1Y: +13.5% 3Y: +500.6% 5Y: +435.9%
$10.45
+0.24 (+2.35%)
 
Weekly Expected Move ±9.7%
$8 $9 $10 $11 $12
NASDAQ · Healthcare · Biotechnology · Tech Score Buy · Power 69 · $1.9B mcap · 173M float · 1.32% daily turnover · Short 33% of daily vol
Credit Risk of going bust: higher than 52% of companies Debt: 13.2% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.19 (down 98%), Xeris Biopharma Holdings, Inc. would be worth roughly what it owes.
Total debt $289.4M against a stock market value of $1.91B.
Distance to default 4.90 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $158.2M (short-term plus half of long-term), stock volatility 54.6%; Altman Z'' -4.14. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview News Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings
Dividends Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest Supply Chain

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NARROW EDGE
57.4 / 100
NoneWeakNarrowWide
Primary source: Network Effects  ·  ROIC: 18.3%
Cost Advantage
59
Intangibles
44
Switching Cost
73
Network Effect
82
Scale
27
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. XERS has a Narrow competitive edge (57.4/100) — meaningful but not impregnable advantages over competitors. The primary source of advantage is Network Effects. ROIC of 18.3% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$12
Low
$14
Avg Target
$16
High
Based on 3 analysts since Aug 6, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 10Hold: 1Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$14.00
Analysts3
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-10-06 Barclays Jenna Davidner $12 $14 +2 +38.2% $10.13
2026-09-10 Leerink Partners Roanna Ruiz Initiated $16 — +107.5% $7.71
2026-08-20 Barclays — $9 $12 +3 +36.7% $8.78
2025-12-08 Barclays — Initiated $9 — +28.8% $6.99
2025-10-29 Oppenheimer Leland Gershell $5 $18 +13 +80.5% $9.97
2025-03-07 Piper Sandler — $3 $4 +1 -5.7% $4.24
2024-11-11 H.C. Wainwright Oren Livnat Initiated $7 — +103.4% $3.25
2024-10-23 Oppenheimer Leland Gershell Initiated $5 — +65.6% $3.02
2024-05-10 Piper Sandler David Amsellem Initiated $3 — +62.4% $1.85
2022-04-28 Craig-Hallum — Initiated $6 — +179.0% $2.33

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C
Oct 27, 2026
DCF
1
ROE
5
ROA
1
D/E
1
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. XERS receives an overall rating of C. Strongest factors: ROE (5/5). Areas of concern: DCF (1/5), ROA (1/5), D/E (1/5), P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-08-06 C+ C
2026-05-07 C C+
2026-05-04 C- C
2026-04-30 C C-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 40 Grade D
Profitability
23
Balance Sheet
32
Earnings Quality
26
Growth
88
Value
23
Momentum
80
Safety
15
Cash Flow
52
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. XERS scores highest in Growth (88/100) and lowest in Safety (15/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
0.66
Distress Zone
Piotroski F-Score
6/9
✗ ✓ ✓ ✓ ✓ ✗ ✗ ✓ ✓
Beneish M-Score
-3.30
Unlikely Manipulator
Ohlson O-Score
-5.20
Bankruptcy prob: 0.5%
Low Risk
Credit Rating
CCC
Score: 19.7/100
Trend: Improving
Earnings Quality
—
OCF/NI: -3.30x
Accruals: -19.8%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. XERS scores 0.66, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. XERS scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. XERS's score of -3.30 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. XERS's implied 0.5% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. XERS receives an estimated rating of CCC (score: 19.7/100), with a improving trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-107.62x
PEG
0.01x
P/S
5.68x
P/B
-185.54x
P/FCF
24.72x
P/OCF
24.18x
EV/EBITDA
92.62x
EV/Revenue
4.58x
EV/EBIT
390.56x
EV/FCF
27.74x
Earnings Yield
-1.25%
FCF Yield
4.05%
Shareholder Yield
1.40%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. XERS currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.000
NI / EBT
×
Interest Burden
-4.363
EBT / EBIT
×
EBIT Margin
0.012
EBIT / Rev
×
Asset Turnover
0.899
Rev / Assets
×
Equity Multiplier
-25.711
Assets / Equity
=
ROE
118.2%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. XERS's ROE of 118.2% is driven by Asset Turnover (0.899), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$10.45
Median 1Y
$7.43
5th Pctile
$2.09
95th Pctile
$26.37
Ann. Volatility
81.0%
Analyst Target
$14.00
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
John Shannon
Chief Executive Officer
 $742,334 $2,848,000 $5,042,584
Kevin McCulloch
President and Chief Operating Officer
 $543,833 $658,600 $2,270,973
Anh Nguyen
 $409,231 $1,128,000 $2,000,648
Medical
edical Officer
 $409,231 $1,128,000 $2,000,648
Beth P. Hecht
Chief Legal Officer and Corporate Secretary
 $517,089 $658,600 $1,895,274
Steven M. Pieper
Chief Financial Officer
 $505,393 $658,600 $1,874,090

CEO Pay Ratio

12:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $5,042,584
Avg Employee Cost (SGA/emp): $419,246
Employees: 435

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
435
+10.4% YoY
Revenue / Employee
$670,908
Rev: $291,845,000
Profit / Employee
$1,274
NI: $554,000
SGA / Employee
$419,246
Avg labor cost proxy
R&D / Employee
$71,644
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE -15.8% -1.9% -2.0% -2.9% -5.0% -1.3% -1.2% -1.6% -2.1% -3.2% -6.2% 21.1% 5.2% 3.0% 2.0% 1.7% 1.1% -7.0% -1.1% 1.2% 1.18%
ROA -62.2% -53.0% -54.6% -58.2% -61.0% -29.2% -23.6% -22.1% -19.6% -18.7% -19.6% -18.0% -19.5% -17.0% -13.8% -9.6% -4.5% 0.2% 3.4% -4.6% -4.60%
ROIC 8.8% -1.1% -98.5% -94.9% -90.8% -53.4% -39.2% -31.6% -23.5% -23.2% -20.6% -17.0% -20.6% -15.6% -10.1% -4.3% -14.3% -41.8% -58.5% 18.3% 18.30%
ROCE -89.2% -51.3% -47.8% -49.9% -51.5% -29.8% -25.3% -20.8% -16.3% -16.2% -14.4% -11.8% -15.6% -12.0% -7.7% -2.2% 5.5% 8.2% 12.3% 1.8% 1.77%
Gross Margin 70.8% 77.4% 71.6% 81.0% 82.3% 81.0% 84.0% 80.1% 83.0% 76.8% 85.3% 78.2% 75.0% 84.2% 85.5% 79.6% 85.2% 77.8% 84.0% 86.4% 86.41%
Operating Margin -2.2% -2.2% -1.3% -74.7% -63.2% -45.8% -40.0% -42.0% -10.2% -22.2% -35.1% -17.0% -23.8% 2.8% -5.1% 6.3% 9.0% 19.5% 9.5% 5.6% 5.62%
Net Margin -2.4% -2.3% -1.5% -1.0% -73.4% -39.0% -50.7% -52.2% -25.2% -30.2% -46.7% -31.2% -29.0% -8.5% -15.3% -2.7% 0.8% 12.9% 2.7% -33.8% -33.77%
EBITDA Margin -2.2% -2.2% -1.2% -79.1% -50.8% -16.3% -22.4% -28.0% -4.8% -7.5% -20.7% -6.5% -15.0% 9.5% 2.0% 12.0% 14.9% 16.5% 14.8% -22.7% -22.74%
FCF Margin -2.2% -1.9% -1.9% -1.5% -1.2% -93.8% -67.1% -56.6% -47.7% -30.8% -26.0% -22.1% -17.9% -18.6% -12.3% -2.7% 7.4% 12.9% 18.2% 16.5% 16.51%
OCF Margin -2.2% -1.9% -1.9% -1.5% -1.2% -93.3% -66.4% -55.0% -46.3% -29.4% -24.7% -21.5% -17.4% -18.2% -12.0% -6.6% 4.0% 9.8% 15.4% 16.9% 16.88%
ROA 3Y Avg snapshot only -10.56%
ROIC Economic snapshot only 10.59%
Cash ROA snapshot only 13.74%
Cash ROIC snapshot only 35.84%
CROIC snapshot only 35.06%
NOPAT Margin snapshot only 8.62%
Pretax Margin snapshot only -5.12%
R&D / Revenue snapshot only 10.38%
SGA / Revenue snapshot only 62.05%
SBC / Revenue snapshot only 8.38%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio -1.74 -2.91 -2.50 -1.53 -1.60 -1.91 -2.87 -5.04 -4.16 -5.21 -4.82 -5.60 -6.73 -9.22 -18.57 -22.76 -92.44 2551.56 85.80 -79.74 -107.621
P/S Ratio 4.61 7.17 5.43 2.61 2.15 1.64 1.84 2.68 1.68 1.98 1.81 1.84 2.27 2.49 3.76 2.96 5.43 4.84 3.27 4.08 5.680
P/B Ratio -66.20 3.75 3.58 2.82 3.85 4.00 7.44 26.38 66.44 -47.86 -33.83 -17.31 -14.99 -17.07 -23.83 -37.73 -1679.22 103.26 79.18 -140.62 -185.536
P/FCF -2.07 -3.70 -2.87 -1.72 -1.82 -1.75 -2.75 -4.74 -3.52 -6.43 -6.97 -8.34 -12.69 -13.35 -30.52 -109.75 72.93 37.42 17.96 24.72 24.717
P/OCF — — — — — — — — — — — — — — — — 136.94 49.38 21.23 24.18 24.180
EV/EBITDA -1.91 -3.02 -2.81 -1.97 -2.32 -3.77 -6.82 -13.07 -16.24 -20.28 -19.89 -30.52 -27.15 -50.40 -241.35 125.30 52.30 38.26 20.72 92.62 92.619
EV/Revenue 4.46 6.89 5.52 2.94 2.60 2.33 2.69 3.76 2.74 2.94 2.87 2.90 3.34 3.47 4.71 3.77 5.23 4.59 3.04 4.58 4.581
EV/EBIT -1.88 -2.97 -2.71 -1.85 -2.13 -3.18 -5.38 -9.75 -10.69 -13.05 -12.97 -17.41 -17.48 -26.49 -61.99 -179.14 99.50 59.61 28.52 390.56 390.558
EV/FCF -2.00 -3.55 -2.91 -1.94 -2.21 -2.49 -4.02 -6.65 -5.75 -9.54 -11.04 -13.15 -18.72 -18.63 -38.18 -139.57 70.24 35.48 16.66 27.74 27.745
Earnings Yield -57.6% -34.3% -39.9% -65.5% -62.5% -52.3% -34.8% -19.9% -24.1% -19.2% -20.7% -17.8% -14.9% -10.8% -5.4% -4.4% -1.1% 0.0% 1.2% -1.3% -1.25%
FCF Yield -48.3% -27.0% -34.9% -58.1% -54.8% -57.2% -36.4% -21.1% -28.4% -15.5% -14.3% -12.0% -7.9% -7.5% -3.3% -0.9% 1.4% 2.7% 5.6% 4.0% 4.05%
PEG Ratio snapshot only 0.009
EV/OCF snapshot only 27.142
EV/Gross Profit snapshot only 5.496
Acquirers Multiple snapshot only 41.988
Shareholder Yield snapshot only 1.40%
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 3.34 1.80 2.67 2.50 2.17 2.54 2.03 1.95 1.82 1.64 2.37 2.26 1.79 1.67 1.72 1.95 1.93 2.19 2.12 1.45 1.449
Quick Ratio 2.95 1.57 2.42 2.22 1.88 2.20 1.68 1.50 1.38 1.23 1.81 1.69 1.29 1.19 1.17 1.24 1.35 1.57 1.50 1.02 1.022
Debt/Equity -35.64 0.92 1.43 1.87 2.52 4.38 6.60 16.49 58.98 -33.79 -29.28 -13.99 -9.57 -9.17 -7.65 -13.32 -44.35 2.76 2.87 -29.74 -29.735
Net Debt/Equity — -0.15 0.06 0.36 0.82 1.68 3.44 10.58 41.91 — — — — — — — — -5.35 -5.72 — —
Debt/Assets 0.67 0.29 0.41 0.43 0.46 0.57 0.62 0.68 0.70 0.71 0.80 0.81 0.84 0.84 0.85 0.77 0.10 0.10 0.10 0.70 0.703
Debt/EBITDA -1.06 -0.77 -1.10 -1.15 -1.25 -2.91 -4.14 -5.83 -8.84 -9.66 -10.87 -15.65 -11.75 -19.40 -61.94 34.79 1.43 1.08 0.81 17.45 17.448
Net Debt/EBITDA 0.06 0.13 -0.05 -0.22 -0.41 -1.12 -2.15 -3.74 -6.28 -6.60 -7.33 -11.15 -8.74 -14.28 -48.47 26.77 -2.01 -2.09 -1.61 10.11 10.109
Interest Coverage -8.40 -16.09 -14.54 -12.01 -9.48 -5.27 -3.37 -2.45 -1.64 -1.39 -1.38 -1.05 -1.20 -0.87 -0.55 -0.17 0.47 0.77 1.17 0.14 0.139
Equity Multiplier -53.34 3.20 3.50 4.31 5.51 7.62 10.69 24.10 84.81 -47.57 -36.68 -17.20 -11.34 -10.91 -8.98 -17.34 -429.95 28.02 30.13 -42.32 -42.316
Cash Ratio snapshot only 0.642
Debt Service Coverage snapshot only 0.587
Cash to Debt snapshot only 0.421
FCF to Debt snapshot only 0.191
Defensive Interval snapshot only 270.2 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.23 0.21 0.25 0.34 0.45 0.34 0.37 0.41 0.48 0.49 0.52 0.55 0.58 0.63 0.68 0.74 0.77 0.83 0.89 0.90 0.899
Inventory Turnover 1.19 1.01 1.21 1.27 1.24 1.06 0.94 0.90 0.94 0.99 0.92 0.88 0.97 0.91 0.90 0.84 0.78 0.91 0.91 0.75 0.754
Receivables Turnover 2.77 4.09 3.94 4.21 4.81 4.57 4.48 4.79 4.16 4.68 5.02 4.99 4.30 5.10 5.32 5.15 5.61 6.38 6.14 6.04 6.035
Payables Turnover 2.63 2.21 2.24 3.25 5.17 3.35 1.88 2.68 3.42 3.88 3.36 4.01 4.13 5.71 6.29 6.08 6.27 19.91 6.51 5.94 5.944
DSO 132 89 93 87 76 80 82 76 88 78 73 73 85 72 69 71 65 57 59 60 60.5 days
DIO 306 363 302 287 295 346 386 407 389 370 399 415 377 402 404 434 469 399 400 484 484.1 days
DPO 139 165 163 112 71 109 194 136 107 94 109 91 88 64 58 60 58 18 56 61 61.4 days
Cash Conversion Cycle 300 287 231 261 301 316 274 346 370 354 363 397 373 409 414 444 476 438 403 483 483.2 days
Fixed Asset Turnover snapshot only 12.606
Operating Cycle snapshot only 544.6 days
Cash Velocity snapshot only 2.755
Capital Intensity snapshot only 1.228
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 1.3% 1.4% 1.4% 1.4% 1.8% 1.2% 90.6% 67.4% 54.6% 48.7% 41.2% 35.3% 22.7% 23.9% 29.9% 35.6% 42.0% 43.7% 41.5% 36.3% 36.33%
Net Income 8.4% -34.7% -71.7% -63.2% -41.3% 22.9% 43.6% 47.7% 53.4% 34.2% 17.2% 16.6% -2.1% 11.9% 30.0% 46.3% 75.2% 1.0% 1.3% 46.4% 46.36%
EPS 36.4% 40.9% 22.1% 20.1% 30.9% 30.8% 44.5% 48.4% 54.1% 35.3% 19.2% 22.8% 5.4% 18.4% 35.5% 48.9% 79.2% 1.0% 1.2% 51.6% 51.59%
FCF 21.1% -19.4% -58.0% -66.8% -47.8% -7.0% 32.5% 37.4% 37.3% 51.2% 45.2% 47.2% 54.1% 25.0% 38.5% 83.4% 1.6% 2.0% 3.1% 9.3% 9.34%
EBITDA 12.3% -43.7% -83.6% -66.5% -34.5% 40.1% 61.6% 67.7% 76.7% 65.1% 48.4% 55.3% 10.5% 41.0% 82.5% 1.4% 2.2% 3.5% 11.6% 1.2% 1.24%
Op. Income 11.1% -37.8% -77.0% -59.5% -33.4% 28.8% 48.1% 47.6% 57.1% 46.3% 32.0% 41.2% 8.5% 23.5% 50.0% 73.6% 1.2% 1.7% 2.6% 4.7% 4.73%
OCF Growth snapshot only 4.50%
Asset Growth snapshot only 23.07%
Debt Growth snapshot only 12.53%
Shares Change snapshot only 10.80%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y 1.9% 1.8% 2.0% 2.4% 2.9% 2.4% 2.0% 1.8% 1.2% 1.0% 85.5% 75.2% 74.4% 59.8% 51.8% 45.4% 39.2% 38.3% 37.4% 35.8% 35.75%
Revenue 5Y — — — — — — — 1.8% 1.6% 1.4% 1.3% 1.5% 1.6% 1.4% 1.2% 1.1% 77.4% 70.2% 63.6% 58.3% 58.32%
EPS 3Y — — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y 1.6% 1.6% 1.7% 2.2% 2.6% 3.3% 3.9% 3.4% 1.5% 1.3% 99.8% 87.3% 84.3% 64.9% 57.7% 48.6% 42.1% 39.6% 37.1% 36.6% 36.61%
Gross Profit 5Y — — — — — — — 1.7% 1.5% 1.3% 1.3% 1.4% 1.5% 1.7% 1.9% 1.7% 96.4% 84.7% 71.2% 65.9% 65.86%
Op. Income 3Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — — — — — — — — —
FCF 5Y — — — — — — — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — — — — — — — — — —
OCF 5Y — — — — — — — — — — — — — — — — — — — — —
Assets 3Y -1.6% 36.4% 28.0% 33.5% 33.2% 46.8% 40.3% 25.6% 24.4% 26.6% 26.2% 29.9% 34.7% 2.0% -2.2% 1.7% 6.9% 3.6% 6.8% 7.8% 7.80%
Assets 5Y — — — — — — — 18.9% 19.0% 21.9% 15.9% 19.9% 20.2% 24.3% 22.1% 15.1% 16.8% 19.2% 18.5% 22.1% 22.15%
Equity 3Y — 8.1% -3.4% -0.4% 8.0% 46.3% 3.5% -17.6% -35.4% — — — — — — — — -32.8% -24.3% — —
Book Value 3Y — -40.1% -46.0% -41.9% -37.0% -14.7% -35.7% -46.3% -55.2% — — — — — — — — -38.8% -30.6% — —
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.87 0.86 0.87 0.88 0.88 0.93 0.96 0.82 0.83 0.87 0.91 0.94 0.95 0.97 0.98 0.99 0.98 0.98 0.98 0.98 0.982
Earnings Stability 0.40 0.46 0.32 0.62 0.58 0.21 0.01 0.22 0.10 0.00 0.06 0.24 0.40 0.72 0.59 0.63 0.62 0.76 0.67 0.70 0.695
Margin Stability 0.70 0.63 0.49 0.51 0.74 0.71 0.54 0.58 0.75 0.80 0.84 0.86 0.87 0.76 0.60 0.62 0.82 0.84 0.91 0.91 0.910
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 1.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 0.00 1.00 1.00 1.00 0.50 1.00 1.00 1.00 1.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.97 0.86 0.50 0.50 0.83 0.91 0.83 0.81 0.50 0.86 0.93 0.93 0.99 0.95 0.88 0.81 0.50 0.20 0.20 0.81 0.815
Earnings Smoothness — — — — — — — — — — — — — — — — — — — — —
ROE Trend — 4.41 1.87 2.70 — -0.10 -0.97 -2.21 — — — — — — — — — — — — —
Gross Margin Trend -0.06 0.26 0.29 0.32 0.20 0.16 0.14 0.11 0.10 0.05 0.04 0.02 -0.02 0.00 -0.01 -0.00 0.03 0.01 0.00 0.02 0.024
FCF Margin Trend 28.91 19.18 12.69 9.03 3.23 2.01 1.70 1.27 1.22 1.13 1.02 0.82 0.65 0.44 0.34 0.37 0.40 0.38 0.37 0.29 0.289
Sustainable Growth Rate — — — — — — — — — — — — — — — — — — — — —
Internal Growth Rate — — — — — — — — — — — — — — — — — 0.2% 3.5% — —
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 0.83 0.78 0.87 0.88 0.87 1.09 1.04 1.03 1.14 0.77 0.66 0.65 0.52 0.67 0.59 0.51 -0.68 51.67 4.04 -3.30 -3.298
FCF/OCF 1.02 1.01 1.01 1.01 1.00 1.00 1.01 1.03 1.03 1.05 1.05 1.03 1.02 1.02 1.03 0.41 1.88 1.32 1.18 0.98 0.978
FCF/Net Income snapshot only -3.226
OCF/EBITDA snapshot only 3.412
CapEx/Revenue 3.3% 2.2% 1.0% 0.8% 0.5% 0.5% 0.6% 1.6% 1.5% 1.4% 1.3% 0.6% 0.4% 0.4% 0.3% 0.1% 0.2% 0.2% 0.3% 0.4% 0.37%
CapEx/Depreciation snapshot only 0.097
Accruals Ratio -0.11 -0.12 -0.07 -0.07 -0.08 0.03 0.01 0.01 0.03 -0.04 -0.07 -0.06 -0.09 -0.06 -0.06 -0.05 -0.08 -0.08 -0.10 -0.20 -0.198
Sloan Accruals snapshot only -0.048
Cash Flow Adequacy snapshot only 46.023
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — — — — — — — — — — 0.0% 0.0% — —
FCF Payout Ratio — — — — — — — — — — — — — — — — 0.0% 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio — — — — — — — — — — — — — — — — — 3.6% 91.9% — —
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.2% 0.1% 0.2% 0.3% 0.3% 0.3% 0.4% 0.3% 0.4% 0.3% 1.2% 1.1% 0.9% 0.7% 1.0% 0.0% 0.0% 0.1% 1.1% 1.4% 1.40%
Net Buyback Yield -16.6% -7.5% -8.6% -14.1% -13.9% -16.3% 0.4% 0.3% 0.4% 0.3% 1.2% 1.1% 0.9% 0.7% 1.0% 0.0% -0.9% -0.3% -0.3% 0.2% 0.19%
Total Shareholder Return -16.6% -7.5% -8.6% -14.1% -13.9% -16.3% 0.4% 0.3% 0.4% 0.3% 1.2% 1.1% 0.9% 0.7% 1.0% 0.0% -0.9% -0.3% -0.3% 0.2% 0.19%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 0.99 0.99 0.99 0.99 0.98 0.98 0.98 0.99 1.01 0.96 0.96 0.95 0.91 1.00 1.00 1.00 1.00 1.000
Interest Burden (EBT/EBIT) 1.12 1.06 1.07 1.08 1.11 1.19 1.30 1.41 1.61 1.72 1.72 1.95 1.83 2.15 2.82 6.83 -1.12 0.02 0.36 -4.36 -4.363
EBIT Margin -2.37 -2.32 -2.03 -1.58 -1.22 -0.73 -0.50 -0.39 -0.26 -0.23 -0.22 -0.17 -0.19 -0.13 -0.08 -0.02 0.05 0.08 0.11 0.01 0.012
Asset Turnover 0.23 0.21 0.25 0.34 0.45 0.34 0.37 0.41 0.48 0.49 0.52 0.55 0.58 0.63 0.68 0.74 0.77 0.83 0.89 0.90 0.899
Equity Multiplier 25.40 3.59 3.59 5.01 8.26 4.62 5.21 7.39 10.71 17.37 31.53 -117.01 -26.53 -17.74 -14.72 -17.27 -23.69 -44.37 -31.99 -25.71 -25.711
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $-1.41 $-1.01 $-1.02 $-1.01 $-0.97 $-0.70 $-0.57 $-0.52 $-0.45 $-0.45 $-0.46 $-0.40 $-0.42 $-0.37 $-0.30 $-0.21 $-0.09 $0.00 $0.07 $-0.10 $-0.10
Book Value/Share $-0.04 $0.78 $0.71 $0.55 $0.40 $0.33 $0.22 $0.10 $0.03 $-0.05 $-0.07 $-0.13 $-0.19 $-0.20 $-0.23 $-0.12 $-0.00 $0.08 $0.07 $-0.06 $-0.06
Tangible Book/Share $-0.04 $-0.48 $-0.41 $-0.55 $-0.67 $-0.72 $-0.81 $-0.91 $-0.95 $-1.01 $-0.99 $-0.99 $-1.03 $-1.02 $-1.01 $-0.87 $-0.64 $-0.54 $-0.54 $-0.67 $-0.67
Revenue/Share $0.53 $0.41 $0.47 $0.59 $0.73 $0.81 $0.88 $0.98 $1.11 $1.19 $1.22 $1.22 $1.26 $1.36 $1.46 $1.58 $1.50 $1.62 $1.77 $1.94 $1.94
FCF/Share $-1.18 $-0.79 $-0.89 $-0.89 $-0.85 $-0.76 $-0.59 $-0.55 $-0.53 $-0.37 $-0.32 $-0.27 $-0.22 $-0.25 $-0.18 $-0.04 $0.11 $0.21 $0.32 $0.32 $0.32
OCF/Share $-1.16 $-0.78 $-0.89 $-0.89 $-0.85 $-0.76 $-0.59 $-0.54 $-0.51 $-0.35 $-0.30 $-0.26 $-0.22 $-0.25 $-0.18 $-0.10 $0.06 $0.16 $0.27 $0.33 $0.33
Cash/Share $1.40 $0.84 $0.98 $0.82 $0.69 $0.90 $0.69 $0.59 $0.48 $0.52 $0.62 $0.52 $0.47 $0.48 $0.38 $0.38 $0.52 $0.62 $0.63 $0.70 $0.70
EBITDA/Share $-1.24 $-0.93 $-0.93 $-0.88 $-0.81 $-0.50 $-0.35 $-0.28 $-0.19 $-0.17 $-0.18 $-0.12 $-0.15 $-0.09 $-0.03 $0.05 $0.15 $0.19 $0.26 $0.10 $0.10
Debt/Share $1.32 $0.72 $1.02 $1.02 $1.02 $1.46 $1.45 $1.64 $1.65 $1.66 $1.91 $1.82 $1.82 $1.82 $1.76 $1.65 $0.21 $0.21 $0.21 $1.67 $1.67
Net Debt/Share $-0.08 $-0.12 $0.04 $0.20 $0.33 $0.56 $0.75 $1.05 $1.17 $1.13 $1.29 $1.30 $1.35 $1.34 $1.38 $1.27 $-0.30 $-0.41 $-0.42 $0.97 $0.97
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 0.662
Altman Z-Prime snapshot only -0.712
Piotroski F-Score 4 5 3 4 5 4 3 2 3 3 5 4 2 5 4 5 7 7 7 6 6
Beneish M-Score -3.05 139.60 144.12 136.11 121.38 -1.70 -2.13 -2.18 -1.74 -2.39 -2.62 -2.42 -2.98 -2.68 -2.47 -2.41 -2.58 -2.52 -2.70 -3.30 -3.296
Ohlson O-Score snapshot only -5.204
Net-Net WC snapshot only $-0.85
EVA snapshot only $13112370.00
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only CCC
Credit Score 20.00 24.06 26.25 24.38 22.73 22.93 20.67 18.81 19.11 20.00 20.00 20.00 20.00 20.00 20.00 12.79 20.00 44.96 47.30 19.69 19.692
Credit Grade snapshot only 17
Credit Trend snapshot only 6.897
Implied Spread (bps) snapshot only 1200.000
Industry Credit Rank snapshot only 9
Sector Credit Rank snapshot only 9

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms